Lupin gets EIR from USFDA for Nagpur facility

Commenting on the development, Lupin MD Nilesh Gupta said, "The successful completion of the Nagpur facility inspection is a positive development as we continue our journey to meet and exceed international regulatory standards."

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2P3NptI
via IFTTT